Speaker Profile

Director, Market Development, 10x Genomics

Victoria Reid is the Director of Market Development at 10x Genomics. She has over 15 years of executive management experience in the Healthcare and Life Science Industries. In her role at 10x Genomics, she is focused on building corporate and partnerships with pharmaceutical companies and expanding the use of 10x's platforms into new markets. Prior to 10x Genomics, she worked for some of the top pharmaceutical companies, including Pfizer, Johnson & Johnson, and GlaxoSmithkline.

Genomic Profiling:
10x Genomics

10x Genomics is a leading company in the field of genomics, located in the San Francisco Bay Area with Corporate Headquarters in Pleasanton, CA.

Accelerating Drug Discovery And Development With Single Cell And Spatial Genomics
We will showcase new approaches for single cell and spatial genomics that can be leveraged to accelerate drug discovery and development in multiple disease areas. Through case studies attendees will better understand how these new technologies can be applied opportunistically across different stages of the drug discovery and development pipeline.

 Session Abstract – PMWC 2020 Silicon Valley

The PMWC 2020 Genomic Profiling Showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.